Glycotest
2012
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Series A
LATEST DEAL TYPE
$10M
LATEST DEAL AMOUNT
2
INVESTORS
Description
Operator of a liver diagnostics company intended to commercialize new and unique blood tests for life-threatening liver cancers and fibrosis-cirrhosis. The company employs unique non-invasive blood tests based on proprietary serum biomarkers, biomarker panels and assay technology that exploit novel sugar-based disease signal chemistry, enabling patients with serious liver disease with novel clinical laboratory testing services.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
- 77 Water Street, Suite 817
- Suite 817
- New York, NY 10005
- United States
+1 (646) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Glycotest’s full profile, request a free trial.
Glycotest Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Corporate (Series A) | 05-Feb-2019 | $10M | 0000 | 000.00 | Completed | Clinical Trials - Phase 3 |
| 3. Buyout/LBO | 31-Dec-2016 | 00.000 | 00.00 | 00.000 | Completed | Generating Revenue |
| 2. Later Stage VC | 25-May-2012 | $801K | $1.3M | Completed | Stealth | |
| 1. Accelerator/Incubator | 05-Jun-2012 | $500K | $500K | Completed | Stealth |
Glycotest Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 000 |
Glycotest Competitors (2)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Fuji | Corporation | Matsuyama, Japan | 0000 | |||
| 0000 | Corporation | Enid, OK | 00 |
Glycotest Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Fosun Pharma | Corporation | Minority | 000 0000 | 000000 0 | ||
| NetScientific | Venture Capital | Majority | 000 0000 | 000000 0 |
Glycotest Executive Team (3)
Glycotest Board Members (8)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Ian Postlethwaite | NetScientific | Board Member | 000 0000 | |
| Joel Zhang | Fosun Pharma | Board Member | 000 0000 | |
| Lawrence Cohen | Glycotest | Chief Executive Officer & Board Member | 000 0000 | |
| Steve Smith | NetScientific | Chairman | 000 0000 | |
| Yu Jing | Fosun Pharma | Board Member | 000 0000 |
3 Former Board Members
You’re viewing 5 of 8 board members. Get the full list »